FC
DTIL icon

FORA Capital’s Precision BioSciences DTIL Stock Holding History

FORA Capital’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-219
Closed -$41K – 966
2020
Q3 		$41K Hold
219
– – 0.03% 470
2020
Q2 		$55K Buy
219
+119
+119% +$26.1K 0.02% 622
2020
Q1 		$18K Buy
+100
New +$26.2K ﹤0.01% 970

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
WHAM
Windmill Hill Asset Management Waddesdon, United Kingdom $321M AUM 25.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FORA Capital's DTIL Position: Q4 2020 in Review

FORA Capital sold out of Precision BioSciences (DTIL) in Q4 2020, closing a stake of 219 shares — an estimated $41K sold.

FORA Capital first reported a position in DTIL in Q1 2020 and held it in 3 quarters. The position peaked at $55K in Q2 2020. 118 funds tracked by Wall St. Rank hold DTIL as of Q4 2020.

  • FORA Capital reported no remaining Precision BioSciences position as of Q4 2020 after selling out during the quarter.
  • FORA Capital sold 219 Precision BioSciences shares in Q4 2020, an estimated $41K.
  • FORA Capital first reported a position in Precision BioSciences in Q1 2020 and held it in 3 quarters.
  • FORA Capital's Precision BioSciences position peaked at $55K in Q2 2020.
  • 118 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2020.

Based on FORA Capital's 13F filing for Q4 2020, filed 12 Feb 2021.